{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:25:28Z","timestamp":1760189128945},"reference-count":36,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":7387,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1989,2]]},"abstract":"<jats:p>T\u2010cell and B\u2010cell functions were studied in 35 patients with untreated multiple myeloma (MM) and in 16 patients with MM treated with prednisolone, melphalan and vincristine. The numbers of CD4+ T cells were normal in untreated MM patients, but markedly decreased in treated patients, whereas CD8+ cell numbers were normal in untreated and treated patients. Mitogen\u2010induced as well as antigen\u2010induced lymphocyte proliferative responses were reduced, but not further affected by treatment. The antigen\u2010induced proliferative responses by lymphocytes of treated, but not of untreated patients, correlated positively to the proportions of CD4+ cells among MNC. Taken together, the findings suggest selective loss of CD4+ subpopulations during cytotoxic treatment. Pokeweed mitogen (PWM)\u2010induced Ig production was generally low, but significantly reduced Ig production was only seen in experiments employing MM B cells and monocytes co\u2010cultured with irradiated T\u2010enriched cells. Irradiated MM T cells displayed normal helper function when co\u2010cultured with normal B cells stimulated with PWM. MM B cells and monocytes cultured with irradiated normal T cells produced little Ig; however, MM monocytes were not suppressive. In 2 of 3 patients with either IgG\u2010\u03ba or IgA\u2010\u03ba myeloma, the numbers of PWM\u2010stimulated B cells that produced \u03ba chains were somewhat higher than those found among normal MNC. The impaired ability of antibody production by B cells from untreated MM patients seems to relate to intrinsic B cell defect(s) rather than to abnormal regulation by T cells or monocytes. However, disturbances in the functions of CD4+ cells may be observed in treated MM.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1989.tb01210.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T14:10:19Z","timestamp":1279462219000},"page":"193-201","source":"Crossref","is-referenced-by-count":10,"title":["B lymphocyte function in multiple myeloma: Analysis of T cell\u2010 and monocyte\u2010dependent antibody production"],"prefix":"10.1111","volume":"42","author":[{"given":"J\u00f8rgen","family":"Peterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aage","family":"Drivsholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ambj\u00f8rnsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebbe","family":"Dickmeiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(63)90140-2"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105098"},{"key":"e_1_2_1_4_2","volume-title":"The monoclonal gammopathies","author":"Kyle RA","year":"1976"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(80)90097-5"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111540"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0308-2261(21)00323-4","article-title":"Immunoregulatory circuits in myeloma","volume":"11","author":"Ullrich S","year":"1982","journal-title":"Clin Haematol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-83-5-625"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197510302931801"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1182\/blood.V60.2.316.316","article-title":"Suppression of lymphocyte responses by monocytes with untreated and treated multiple myeloma","volume":"60","author":"Twomey JJ","year":"1982","journal-title":"Blood"},{"key":"e_1_2_1_11_2","first-page":"75","article-title":"Autologous mixed lymphocyte reaction in multiple myeloma patients: effect of adherent mononuclear cells and T lymphocytes","volume":"40","author":"Lahat N","year":"1986","journal-title":"Diagnostic Immunol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb07273.x"},{"key":"e_1_2_1_13_2","first-page":"512","article-title":"Enhanced T cell suppression is directed toward sensitive circulating B cells in multiple myeloma","volume":"99","author":"Perri RT","year":"1982","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110095"},{"key":"e_1_2_1_15_2","first-page":"120","article-title":"Regulation of the in vitro monoclonal immunoglobulin production in cultures of peripheral blood mononuclear cells and bone marow cells from myeloma patients mediated by T cell dependent mitogens","volume":"65","author":"Peest D","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1982.tb00689.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1985.tb07441.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00915255"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320493"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1982.tb00594.x"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00270347"},{"key":"e_1_2_1_22_2","first-page":"265","article-title":"Treatment of rheumatoid arthritis with bestatin","volume":"21","author":"Hansen TM","year":"1984","journal-title":"Clin Trials J"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00320524"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.4049\/jimmunol.118.5.1864","article-title":"Multiple myeloma: an immunologic profile. I. Peripheral blood studies","volume":"118","author":"Mackenzie MR","year":"1977","journal-title":"J Immunol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1979.tb01379.x"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1982.tb00563.x"},{"key":"e_1_2_1_27_2","first-page":"653","article-title":"Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease","volume":"56","author":"Lauria F","year":"1984","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_28_2","first-page":"23","article-title":"Analysis of the relationship between T cell subsets and in vitro B cell responses in multiple myeloma","volume":"16","author":"Levinson AI","year":"1985","journal-title":"J Clin Lab Immunol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830220205"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(87)90116-4"},{"key":"e_1_2_1_31_2","first-page":"533","article-title":"Production of interleukin 2 in multiple myeloma","volume":"63","author":"Commes T","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_32_2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood.V66.6.1266.1266","article-title":"Abnormal clonogenic potential of T cells from multiple myeloma patients","volume":"66","author":"Pilarski LM","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19811115)48:10<2211::AID-CNCR2820481016>3.0.CO;2-5"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1984.tb03995.x"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1182\/blood.V66.2.416.416","article-title":"Pre\u2010B cells in peripheral blood of multiple myeloma patients","volume":"66","author":"Pilarski LM","year":"1985","journal-title":"Blood"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111921"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4049\/jimmunol.139.1.24","article-title":"Multiple myeloma: an immunologic profile. IV. The EA rosetteforming cell is a Leu\u20101 positive immunoregulatory B cell","volume":"139","author":"MacKenzie MR","year":"1987","journal-title":"J Immunol"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1989.tb01210.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1989.tb01210.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T01:12:18Z","timestamp":1697937138000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1989.tb01210.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1989,2]]}},"alternative-id":["10.1111\/j.1600-0609.1989.tb01210.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1989.tb01210.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,2]]}}}